SE9201187L - Potentiering av antimikrobiell effekt - Google Patents

Potentiering av antimikrobiell effekt

Info

Publication number
SE9201187L
SE9201187L SE9201187A SE9201187A SE9201187L SE 9201187 L SE9201187 L SE 9201187L SE 9201187 A SE9201187 A SE 9201187A SE 9201187 A SE9201187 A SE 9201187A SE 9201187 L SE9201187 L SE 9201187L
Authority
SE
Sweden
Prior art keywords
pct
composition
preparation
monoglyceride
sec
Prior art date
Application number
SE9201187A
Other languages
English (en)
Other versions
SE9201187D0 (sv
SE500777C2 (sv
Inventor
K Oelund
L-K Luetz
R Bryland
Aake Lindahl
Original Assignee
Hydro Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hydro Pharma Ab filed Critical Hydro Pharma Ab
Priority to SE9201187A priority Critical patent/SE500777C2/sv
Publication of SE9201187D0 publication Critical patent/SE9201187D0/sv
Priority to SG1996003104A priority patent/SG52341A1/en
Priority to NZ251783A priority patent/NZ251783A/en
Priority to DK93909105T priority patent/DK0636024T3/da
Priority to JP51822193A priority patent/JP4014114B2/ja
Priority to AU39639/93A priority patent/AU677580B2/en
Priority to DE69325450T priority patent/DE69325450T2/de
Priority to PCT/SE1993/000275 priority patent/WO1993020812A1/en
Priority to EP93909105A priority patent/EP0636024B1/en
Priority to US08/307,763 priority patent/US5550145A/en
Priority to CA002118114A priority patent/CA2118114C/en
Priority to ES93909105T priority patent/ES2132230T3/es
Priority to AT93909105T priority patent/ATE181502T1/de
Publication of SE9201187L publication Critical patent/SE9201187L/sv
Publication of SE500777C2 publication Critical patent/SE500777C2/sv
Priority to HK98108909A priority patent/HK1007923A1/xx
Priority to GR990402077T priority patent/GR3030999T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SE9201187A 1992-04-14 1992-04-14 Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav SE500777C2 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE9201187A SE500777C2 (sv) 1992-04-14 1992-04-14 Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
AT93909105T ATE181502T1 (de) 1992-04-14 1993-03-31 Potenzierung von antimikrobiellen wirkungen
DE69325450T DE69325450T2 (de) 1992-04-14 1993-03-31 Potenzierung von antimikrobiellen wirkungen
EP93909105A EP0636024B1 (en) 1992-04-14 1993-03-31 Potentiation of antimicrobial effects
DK93909105T DK0636024T3 (da) 1992-04-14 1993-03-31 Potensering af antimikrobielle virkninger
JP51822193A JP4014114B2 (ja) 1992-04-14 1993-03-31 抗菌作用の増強剤
AU39639/93A AU677580B2 (en) 1992-04-14 1993-03-31 Potentiation of antimicrobial effects
SG1996003104A SG52341A1 (en) 1992-04-14 1993-03-31 Potentiation of antimicrobial effects
PCT/SE1993/000275 WO1993020812A1 (en) 1992-04-14 1993-03-31 Potentiation of antimicrobial effects
NZ251783A NZ251783A (en) 1992-04-14 1993-03-31 Antimicrobial compositions comprising monoglyceride of lauric or monomyriotic acid with urea, fusidic acid, econazole nitrate, mikonazole nitrate, tinidazole, metronidazole or petanediol
US08/307,763 US5550145A (en) 1992-04-14 1993-03-31 Potentiation of antimicrobial effects
CA002118114A CA2118114C (en) 1992-04-14 1993-03-31 Potentiation of antimicrobial effects
ES93909105T ES2132230T3 (es) 1992-04-14 1993-03-31 Potenciacion de efectos antimicrobianos.
HK98108909A HK1007923A1 (en) 1992-04-14 1998-07-06 Potentiation of antimicrobial effects
GR990402077T GR3030999T3 (en) 1992-04-14 1999-08-18 Potentiation of antimicrobial effects.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201187A SE500777C2 (sv) 1992-04-14 1992-04-14 Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav

Publications (3)

Publication Number Publication Date
SE9201187D0 SE9201187D0 (sv) 1992-04-14
SE9201187L true SE9201187L (sv) 1993-10-15
SE500777C2 SE500777C2 (sv) 1994-08-29

Family

ID=20385960

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201187A SE500777C2 (sv) 1992-04-14 1992-04-14 Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav

Country Status (15)

Country Link
US (1) US5550145A (sv)
EP (1) EP0636024B1 (sv)
JP (1) JP4014114B2 (sv)
AT (1) ATE181502T1 (sv)
AU (1) AU677580B2 (sv)
CA (1) CA2118114C (sv)
DE (1) DE69325450T2 (sv)
DK (1) DK0636024T3 (sv)
ES (1) ES2132230T3 (sv)
GR (1) GR3030999T3 (sv)
HK (1) HK1007923A1 (sv)
NZ (1) NZ251783A (sv)
SE (1) SE500777C2 (sv)
SG (1) SG52341A1 (sv)
WO (1) WO1993020812A1 (sv)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411899A1 (de) * 1994-04-07 1995-10-12 Beiersdorf Ag Gegen Fußgeruch wirksame Zubereitungen mit einem Gehalt an Monoglycerinestern von Fettsäuren
BR9507669A (pt) * 1994-05-20 1997-10-07 Novavax Inc Emulsões de óleo em água antibacteriais
US5460802A (en) * 1994-07-18 1995-10-24 Minnesota Mining And Manufacturing Company Oral disinfectant for companion animals
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
DE4434775A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen
DE4435290A1 (de) * 1994-10-01 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen
DE4436537A1 (de) * 1994-10-13 1996-04-18 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen
DE4438588A1 (de) * 1994-10-28 1996-05-02 Beiersdorf Ag Gegen unreine Haut, leichte Formen der Akne sowie Propionibacterium acnes wirksame Wirkstoffkombinationen auf der Basis von Wollwachssäuren und Glycerinestern gesättigter Fettsäuren
DE4444237C2 (de) * 1994-12-13 2000-08-24 Beiersdorf Ag Verwendung von Wirkstoffkombinationen zur Bekämpfung durch Propionibacterium acnes hervorgerufener unreiner Haut sowie leichter Formen der Akne
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
US5700842A (en) * 1995-11-01 1997-12-23 Kimberly-Clark Worldwide, Inc. Methods of incorporating a hydrophobic substance into an aqueous solution
DE19541967A1 (de) * 1995-11-10 1997-05-15 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Zusammensetzungen auf der Basis von Partialglyceriden und Arylverbindungen
ES2157131T3 (es) 1998-02-12 2001-08-01 Oreal Utilizacion del 1,2-pentanodiol en una composicion cosmetica o dermatologica que contiene una dispersion acuosa de polimero filmogeno, y composicion cosmetica o dermatologica que comprende estos constituyentes.
IL137891A (en) * 1998-03-19 2005-03-20 Bifodan As Disinfecting composition
CA2335550A1 (en) * 1998-06-23 1999-12-29 University Of Maryland Use of oils having a high lauric acid content as an animal feed
US6096332A (en) 1998-06-30 2000-08-01 Mcneil-Ppc, Inc. Adding pharmaceutically active compounds to substrates
IT1317735B1 (it) * 2000-01-26 2003-07-15 Nicox Sa Sali di agenti antimicrobici.
US7074832B2 (en) 2001-09-24 2006-07-11 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
SE0103528D0 (sv) * 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
DE10205190B4 (de) * 2002-02-08 2017-06-08 Beiersdorf Ag 2-Methyl-1,3-propandiol haltige Zubereitungen
US20050036972A1 (en) * 2003-03-10 2005-02-17 Hy-Gene Biomedical Corporation System for managing pathogens and irritants and monitoring usage of anti-bacterial formulations
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
JP4091566B2 (ja) * 2003-06-03 2008-05-28 株式会社マンダム 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品
SE0301862D0 (sv) * 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
US7214391B2 (en) * 2003-06-30 2007-05-08 Usana Health Sciences, Inc. Botanical extract compositions and process for preparing same
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
JP2007504826A (ja) * 2003-09-09 2007-03-08 スリーエム イノベイティブ プロパティズ カンパニー 濃厚な抗菌性組成物および方法
CN1867251A (zh) * 2003-09-09 2006-11-22 3M创新有限公司 抗菌组合物和方法
WO2005047475A2 (en) * 2003-11-11 2005-05-26 Regents Of The University Of Minnesota Regulation of cell membrane-mediated effects
FR2869802B1 (fr) * 2004-05-04 2010-08-20 I N E A S L Composition cosmetique et/ou dermatologique possedant des proprietes conservatrices hypoalergeniques
US8796332B2 (en) * 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
EP1812550A2 (en) * 2004-10-20 2007-08-01 Iogenetics, Llc Biocides
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
CA2599667C (en) 2005-03-10 2014-12-16 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxy carboxylic acids
CA2598985A1 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Antimicrobial pet wipes and methods
US8476319B2 (en) 2005-03-10 2013-07-02 3M Innovative Properties Company Methods of treating ear infections
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
EP2497459B1 (en) 2005-03-10 2019-04-24 3M Innovative Properties Company Methods of reducing microbial contamination
AU2007211734A1 (en) * 2006-02-02 2007-08-09 Leo Pharma A/S A topical composition comprising an antibacterial substance
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
WO2010047831A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
FR2954124B1 (fr) * 2009-12-18 2012-04-06 Fabre Pierre Dermo Cosmetique Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee
US20130165880A1 (en) 2010-09-17 2013-06-27 David T. Amos Antimicrobial disposable absorbent articles
JP2014512408A (ja) * 2011-04-29 2014-05-22 エフィック ソシエテ アノニム アルキルポリグルコシドをベースとする膣用組成物
GB201118193D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to oranic compounds
GB201118198D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to organic compounds
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
MX2018015475A (es) * 2016-06-13 2019-07-12 Vyome Therapeutics Ltd Composiciones antifungicas sinérgicas y métodos de las mismas.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK116528A (sv) * 1966-09-30
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
JPS5814758B2 (ja) * 1977-08-23 1983-03-22 株式会社日立製作所 多層配線基板
JPS58111669A (ja) * 1981-12-25 1983-07-02 Takeda Chem Ind Ltd 食品用防腐剤および食品の防腐方法
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
CA1331559C (en) * 1986-04-21 1994-08-23 Jon Joseph Kabara Antimicrobial preservative compositions and methods
NZ221168A (en) * 1986-08-15 1989-08-29 Colgate Palmolive Co Antiseptic composition containing ethyl alcohol and monolaurin
US4997851A (en) * 1987-12-31 1991-03-05 Isaacs Charles E Antiviral and antibacterial activity of fatty acids and monoglycerides
US4847088A (en) * 1988-04-28 1989-07-11 Dow Corning Corporation Synergistic antimicrobial composition
KR960016205B1 (ko) * 1989-03-13 1996-12-06 셀레지 파마슈티컬스, 인코포레이티드 피부질환 및 종양치료를 위한 약제 조성물
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
EP0593459B1 (en) * 1990-04-18 1997-01-22 The Procter & Gamble Company Anti-lice treatment compositions
FI912955A (fi) * 1990-06-25 1991-12-26 Res Found Mental Hygiene Antimikroba fettsyrasammansaettningar.
NZ250714A (en) * 1990-10-30 1996-05-28 Mcneil Ppc Inc Liquid composition comprising esters of higher fatty acids for use as a vaginal douche and to prevent toxic shock toxin production

Also Published As

Publication number Publication date
GR3030999T3 (en) 1999-12-31
CA2118114C (en) 2003-06-17
EP0636024B1 (en) 1999-06-23
AU677580B2 (en) 1997-05-01
SG52341A1 (en) 1998-09-28
CA2118114A1 (en) 1993-10-28
HK1007923A1 (en) 1999-04-30
US5550145A (en) 1996-08-27
AU3963993A (en) 1993-11-18
ES2132230T3 (es) 1999-08-16
DE69325450D1 (de) 1999-07-29
DK0636024T3 (da) 1999-11-22
DE69325450T2 (de) 1999-12-23
JP4014114B2 (ja) 2007-11-28
ATE181502T1 (de) 1999-07-15
EP0636024A1 (en) 1995-02-01
JPH07505880A (ja) 1995-06-29
NZ251783A (en) 1996-07-26
SE9201187D0 (sv) 1992-04-14
WO1993020812A1 (en) 1993-10-28
SE500777C2 (sv) 1994-08-29

Similar Documents

Publication Publication Date Title
SE9201187L (sv) Potentiering av antimikrobiell effekt
US4911932A (en) Skin care compositions
DE69533593D1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
RU94041836A (ru) Производные амидина, смесь их изомеров или отдельные изомеры и их соли, фармацевтическая композиция с антагонистической в отношении лейкотриена в*004 активностью
US20080020025A1 (en) Composition for wound care and method of using same
ATE406154T1 (de) Zusammensetzung enthaltend ozonisierte öle und/oder andere natürliche und/oder synthetische ozonizierte produkte und ihre verwendung in pharmazeutischen, kosmetischen, diätetischen oder nahrungsergänzenden zusammensetzungen in human- und veterinärgebieten
KR102272901B1 (ko) 메조-2,3-부탄디올을 방부제로서 함유하는 피부 외용제 조성물
JP2844103B2 (ja) 皮膚外用剤
JPH06157278A (ja) 尋常性ざ瘡用皮膚外用剤
DE69508918T2 (de) Synergistische antimikrobielle zusammensetzung die methylen-bis-thiocyanat enthält
ATE363909T1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
Matousek et al. The effects of four acidifying sprays, vinegar, and water on canine cutaneous pH levels
JPS56113706A (en) Mildewcide composition for industrial use
US20050282895A1 (en) Antimicrobial compositions and methods of use thereof
JPH03157311A (ja) にきび用化粧料
GB2094623A (en) Compositions containing hydrogen peroxide
KR20200082041A (ko) 로즈마리 추출물 및 아스코르브산류를 유효성분으로 함유하는 항균용 조성물
WO2012172318A1 (en) Formulations containing tropolonoids, copper salt and a solvent system
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
Jelenko et al. Topical lipid protection of burned subjects and their wounds
CA1102238A (en) Composition for treating burns
SE9302006D0 (sv) Protein formulation
KR20060112839A (ko) 목초액 및 숯 분말을 함유하는 풋케어 화장료 조성물
GEP20002241B (en) Polymorphs and Hydrated Forms of Lesopitron Dichlorohydrate, Methods for Its Preparation and Pharmaceutical Compositions Containing Same
JPH0489417A (ja) コロミン酸含有化粧料